APLMW vs REGN: Which Stock is Better?

Side-by-side comparison of Apollomics Inc. and Regeneron Pharmaceuticals Inc in 2026

Comparison Updated:

APLMW

Apollomics Inc.

$0.01

REGN

Regeneron Pharmaceuticals Inc

$753.93

Key Metrics Comparison

MetricAPLMWREGNWinner
Market Cap$41.26M$79.87BREGN
P/E RatioN/A18.21REGN
EPS (TTM)$N/A$41.48REGN
Revenue Growth0.0%0.0%REGN
Gross Margin0.0%44.6%REGN

Analyze APLMW

Full quant analysis

Analyze REGN

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is APLMW or REGN a better investment?

Comparing APLMW and REGN: Apollomics Inc. has a market cap of $41.26M while Regeneron Pharmaceuticals Inc has $79.87B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between APLMW and REGN?

APLMW (Apollomics Inc.) and REGN (Regeneron Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: APLMW or REGN?

Based on P/E ratios, compare detailed valuation metrics on our dashboard.

Which is growing faster: APLMW or REGN?

REGN has higher revenue growth at 0.0% vs 0.0% for APLMW.

Which company is more profitable: APLMW or REGN?

Regeneron Pharmaceuticals Inc (REGN) has higher gross margins at 44.6% compared to 0.0% for APLMW.

Which is the larger company: APLMW or REGN?

Regeneron Pharmaceuticals Inc (REGN) is larger with a market cap of $79.87B compared to $41.26M for APLMW.

Should I buy APLMW or REGN in 2026?

Both APLMW and REGN have investment merit. APLMW trades at $0.01 while REGN trades at $753.93. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between APLMW and REGN stock?

Key differences: Market Cap ($41.26M vs $79.87B), P/E Ratio (N/A vs 18.2x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 44.6%).

Popular Stock Comparisons